MUFG Americas’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-33,139
| Closed | -$5.87M | – | 745 |
|
|
2020
Q1 | $5.87M | Sell |
33,139
-35,438
| -52% | -$6.67M | 0.19% | 125 |
|
|
2019
Q4 | $13.1M | Sell |
68,577
-2,866
| -4% | -$517K | 0.34% | 81 |
|
|
2019
Q3 | $12M | Sell |
71,443
-3,425
| -5% | -$558K | 0.33% | 84 |
|
|
2019
Q2 | $12.5M | Buy |
74,868
+6,557
| +10% | +$908K | 0.35% | 79 |
|
|
2019
Q1 | $10M | Buy |
68,311
+8,545
| +14% | +$1.24M | 0.29% | 103 |
|
|
2018
Q4 | $7.99M | Sell |
59,766
-6,646
| -10% | -$1.09M | 0.25% | 109 |
|
|
2018
Q3 | $12.7M | Buy |
66,412
+9,416
| +17% | +$1.73M | 0.36% | 82 |
|
|
2018
Q2 | $9.5M | Buy |
56,996
+6,463
| +13% | +$1.04M | 0.29% | 104 |
|
|
2018
Q1 | $8.5M | Buy |
50,533
+11,711
| +30% | +$1.96M | 0.26% | 117 |
|
|
2017
Q4 | $6.35M | Buy |
38,822
+1,017
| +3% | +$183K | 0.19% | 137 |
|
|
2017
Q3 | $7.75M | Sell |
37,805
-3,163
| -8% | -$736K | 0.25% | 115 |
|
|
2017
Q2 | $9.96M | Buy |
40,968
+1,934
| +5% | +$454K | 0.32% | 94 |
|
|
2017
Q1 | $9.33M | Buy |
39,034
+3,419
| +10% | +$796K | 0.31% | 95 |
|
|
2016
Q4 | $7.48M | Sell |
35,615
-891
| -2% | -$185K | 0.25% | 113 |
|
|
2016
Q3 | $8.41M | Buy |
36,506
+179
| +0.5% | +$43.7K | 0.29% | 100 |
|
|
2016
Q2 | $8.4M | Buy |
36,327
+10,072
| +38% | +$2.32M | 0.29% | 97 |
|
|
2016
Q1 | $7.04M | Buy |
26,255
+3,928
| +18% | +$1.12M | 0.25% | 105 |
|
|
2015
Q4 | $6.98M | Buy |
22,327
+5,867
| +36% | +$1.75M | 0.25% | 100 |
|
|
2015
Q3 | $4.47M | Buy |
16,460
+3,411
| +26% | +$1.05M | 0.17% | 139 |
|
|
2015
Q2 | $3.96M | Buy |
13,049
+4,750
| +57% | +$1.42M | 0.13% | 155 |
|
|
2015
Q1 | $2.47M | Buy |
8,299
+5,868
| +241% | +$1.67M | 0.08% | 200 |
|
|
2014
Q4 | $626K | Buy |
2,431
+694
| +40% | +$173K | 0.02% | 352 |
|
|
2014
Q3 | $420K | Buy |
1,737
+1,187
| +216% | +$266K | 0.01% | 401 |
|
|
2014
Q2 | $123K | Sell |
550
-50
| -8% | -$10.4K | ﹤0.01% | 543 |
|
|
2014
Q1 | $124K | Hold |
600
| – | – | ﹤0.01% | 546 |
|
|
2013
Q4 | $101K | Sell |
600
-20
| -3% | -$3.13K | ﹤0.01% | 585 |
|
|
2013
Q3 | $89K | Sell |
620
-2,560
| -81% | -$341K | ﹤0.01% | 619 |
|
|
2013
Q2 | $401K | Buy |
+3,180
| New | +$360K | 0.01% | 731 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
MUFG Americas's AGN Position: Q2 2020 in Review
MUFG Americas sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 33,139 shares — an estimated $5.87M sold.
MUFG Americas first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $13.1M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- MUFG Americas reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- MUFG Americas sold 33,139 Allergan plc shares in Q2 2020, an estimated $5.87M.
- MUFG Americas first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- MUFG Americas's Allergan plc position peaked at $13.1M in Q4 2019.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on MUFG Americas's 13F filing for Q2 2020, filed 6 Aug 2020.